MEITAV INVESTMENT HOUSE LTD
Position in NRSN — NeuroSense Therapeutics Ltd.
CIK 1398346
BENE-BERAQ, L3
Position in NRSN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$30,200
-$560 QoQ
Shares Held
40,000
0.0% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 13 holders
Holding Since
Mar 2023
13 quarters on record
Common Shares in NRSN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEITAV INVESTMENT HOUSE LTD holds $8,599,446 across 5 Biotechnology names. NRSN ranks #5 (0.4% of the industry book) .
All Filings in NRSN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,200 | 40,000 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $30,760 | 40,000 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $50,000 | 40,000 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $75,600 | 40,000 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $37,200 | 40,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $48,000 | 40,000 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $50,800 | 40,000 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $44,800 | 40,000 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $91,000 | 50,000 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $74,575 | 95,000 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $67,450 | 95,000 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $141,550 | 95,000 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $163,400 | 95,000 | Shares | Defined | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||